The effect of quinagolide and cabergoline, two selective dopamine receptor type 2 agonists, in the treatment of prolactinomas - Di Sarno, A; Landi, M L; Marzullo, P; Di Somma, C; Pivonello, R; Cerbone, G; Lombardi, G; Colao, A (Clin Endocrinol (Oxf), 2000)